Brief: Dotz Nano Says It Entered Collaboration Agreement With Theracell Labs
12/04/2022 02:24
April 12 (Reuters) - Dotz Nano Ltd DTZ.AX :
* ENTERED COLLABORATION AGREEMENT FOR CO-DEVELOPMENT, SUPPLY
AND
LICENSING WITH THERACELL LABS
* UNDER DEAL, THERACELL LABS COMMITTED TO A MINIMUM PURCHASE
ORDER
OF US$5 MLN IN FIRST YEAR FROM CO
* THERACELL LABS HAS COMMITTED TO PURCHASE ORDER OF
DOTZ-TAGGED
DISPOSABLE BIOPROCESSING CONSUMABLES
* ON SUCCESSFUL DEVELOPMENT OF PRODUCT, THERACELL LABS
REQUIRED TO
PAY DOTZ 5% OF NET REVENUE FROM SALE OF PRODUCT
Source text for Eikon: ID:nASX7CKHys
Further company coverage: DTZ.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orgenesis
See all newsBrief: Orgenesis Nasdaq To Delist Co'S Common Stock, Securities Trading Will Be Suspended On Oct 21
Brief: Orgenesis Announces Positive Results From A Real-World Study Of Org-101 Car-T Therapy
Brief: Orgenesis Announces Strategic Partnership With Harley Street Healthcare Group
Brief: Orgenesis Says Entered Purchase Deal With Theracell For Purchase Of 50% Outstanding Ownership Rights & Equity Interests In Theracell Laboratories Ike
Brief: Orgenesis Received Nasdaq Hearings Panel Decision Which Granted Company Until October 14 To Regain Compliance With Bid Price And Equity Rules